DOCS - NYSE

Doximity, Inc.

Doximity, Inc.

DOCS·NYSE

$21.12

+1.2%
HealthcareMedical - Healthcare Information Services

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$3.95B
EPS1.0500
P/E Ratio20.12
Earnings Date08/06/2026
326.46M
Operating Cash Flow
19%
3Y+82.0%
5Y+293.0%
10Y+2033.0%
147.17M
Investing Cash Flow
-602%
3Y-346.0%
5Y-309.0%
10Y-1723.0%
-464.06M
Financing Cash Flow
254%
3Y+523.0%
5Y-8683.0%
10Y-47213.0%
DOCS

Doximity, Inc. Cash Conversion Engine

DOCS · NYSE
Net Income196.05M
Depreciation & Amortization14.38M
Stock-Based Compensation121.63M
Change in Working Capital0.00
Others-37.74M
Capital Expenditures0.00
Free Cash Flow326.46M

Cash Flow Quality Analysis

FCF Conversion Rate

166.5%

Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.

FCF Growth Trend

+22.4%

Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.

Working Capital Impact

+$0.00

Neutral working capital impact. Changes in current assets and liabilities balanced out.

Cash Flow Quality Insight

Exceptional cash generation: High-quality earnings converting to growing free cash flow. The company demonstrates strong pricing power, efficient operations, and disciplined capital allocation.

Doximity, Inc. Cash Flow Statement

DOCS • NYSE

Doximity, Inc. Cash Flow StatementMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
OPERATING ACTIVITIES
Net Income
196.1M
223.2M
147.6M
112.8M
154.8M
50.2M
29.7M
7.8M
Depreciation & Amortization
14.4M
10.7M
10.3M
10.3M
5M
10.6M
900K
551K
Change in Deferred Taxes
32.1M
-11.6M
-8.6M
13.2M
-41.2M
5M
-7.1M
480K
Stock-Based Compensation
121.6M
72.4M
51.1M
47.8M
31.4M
7.3M
2.4M
2.3M
Other Non-Cash Items
-37.7M
2.7M
8.3M
16.5M
16.9M
-95K
6.6M
5.2M
Cash Taxes Paid
(0.0)
(55.7M)
(51.3M)
(5.2M)
(206K)
(6M)
(1.2M)
(4K)
Change in Working Capital
0.0
-24.1M
-24.5M
-21M
-40.3M
10M
-6.3M
-1.1M
Cash from Operating Activities
326.5M
273.3M
184.1M
179.6M
126.6M
83M
26.2M
15.3M
INVESTING ACTIVITIES
Investments in Property, Plant, and Equipment
(0.0)
-6.5M
-147K
-6.2M
-5.7M
-4.6M
-4.2M
-1.2M
Acquisitions, Net
(0.0)
(0.0)
(0.0)
-53.5M
(0.0)
-27.5M
(4M)
(1.1M)
Purchase of Investments
-389.2M
-675.6M
-472.9M
-190.6M
-1.3B
-78.9M
-79.1M
-61.7M
Sale/Maturity of Investments
571.8M
652.8M
509.9M
190.3M
681.7M
40.5M
70.3M
53.9M
Other Investing Items
-35.5M
0.0
-5.7M
0.0
595K
-12K
-4M
-1.1M
Cash from Investing Activities
(147.2M)
-29.3M
(31.2M)
-59.9M
-640.6M
-70.4M
-13.1M
-9.1M
FINANCING ACTIVITIES
Net Issuance of Common Stock
0.0
-97M
-280.7M
-85.3M
551.2M
-2M
0.0
0.0
Share Repurchases
(3.9M)
-120.3M
-280.7M
-85.3M
-2.7M
-2M
(0.0)
(0.0)
Other Financing Items
-464.1M
-34.1M
4.2M
10.9M
9.2M
7.4M
1.7M
985K
Cash from Financing Activities
-464.1M
-131.1M
-276.5M
-74.5M
560.4M
5.4M
1.7M
985K
CASH FLOW SUMMARY
Net Change in Cash
9.6M
112.8M
-61.2M
45.2M
46.4M
18M
14.8M
7.2M
Cash at Beginning of Period
209.6M
96.8M
158M
112.8M
66.4M
48.4M
33.6M
26.4M
Cash at End of Period
219.2M
209.6M
96.8M
158M
112.8M
66.4M
48.4M
33.6M
Free Cash Flow
326.5M
266.7M
178.3M
173.4M
120.9M
78.4M
22M
14.1M

SEC Filings

DOCS - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
10-K

10-K 2026 FY

FY

May 19, 2026
March 31, 2026
2026
View Filing
8-K

8-K 2026

N/A

May 13, 2026
May 13, 2026
2026
View Filing
8-K

8-K 2026

N/A

April 17, 2026
April 13, 2026
2026
View Filing
10-Q

10-Q 2025 Q4

Q4

February 05, 2026
December 31, 2025
2025
View Filing
8-K

8-K 2026

N/A

February 05, 2026
February 03, 2026
2026
View Filing
8-K

8-K 2025

N/A

December 30, 2025
December 24, 2025
2025
View Filing
10-Q

10-Q 2025 Q3

Q3

November 06, 2025
September 30, 2025
2025
View Filing
8-K

8-K 2025

N/A

November 06, 2025
November 06, 2025
2025
View Filing
8-K

8-K 2025

N/A

September 02, 2025
August 28, 2025
2025
View Filing
8-K

8-K 2025

N/A

August 15, 2025
August 13, 2025
2025
View Filing
Showing 1 to 10 of 56 filings

Related Guides

Blog Categories

Continue your DOCS research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.